205 related articles for article (PubMed ID: 36264653)
1. Biologics for chronic spontaneous urticaria: toward a personalized treatment.
Asero R; Ferrucci S; Tedeschi A; Cugno M
Expert Rev Clin Immunol; 2022 Dec; 18(12):1297-1305. PubMed ID: 36264653
[TBL] [Abstract][Full Text] [Related]
2. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of chronic spontaneous urticaria and their clinical implications.
Asero R; Cugno M
Expert Rev Clin Immunol; 2021 Mar; 17(3):247-254. PubMed ID: 33496195
[No Abstract] [Full Text] [Related]
4. New biologics in the treatment of urticaria.
Kocatürk E; Zuberbier T
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):425-431. PubMed ID: 30015639
[TBL] [Abstract][Full Text] [Related]
5. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
[TBL] [Abstract][Full Text] [Related]
7. Biologics in Chronic Urticaria.
Bulkhi A; Cooke AJ; Casale TB
Immunol Allergy Clin North Am; 2017 Feb; 37(1):95-112. PubMed ID: 27886913
[TBL] [Abstract][Full Text] [Related]
8. Unveiling chronic spontaneous urticaria pathophysiology through systems biology.
Segú-Vergés C; Gómez J; Terradas-Montana P; Artigas L; Smeets S; Ferrer M; Savic S
J Allergy Clin Immunol; 2023 Apr; 151(4):1005-1014. PubMed ID: 36587849
[TBL] [Abstract][Full Text] [Related]
9. BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria.
Bernstein JA; Maurer M; Saini SS
J Allergy Clin Immunol; 2024 May; 153(5):1229-1240. PubMed ID: 38141832
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab in severe chronic urticaria: are slow and non-responders different?
Asero R
Eur Ann Allergy Clin Immunol; 2021 Nov; 53(6):263-266. PubMed ID: 32914943
[No Abstract] [Full Text] [Related]
11. Emerging treatments for chronic urticaria.
Wedi B
Expert Opin Investig Drugs; 2022 Mar; 31(3):281-290. PubMed ID: 35166638
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
Giménez-Arnau AM
Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D
Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
[TBL] [Abstract][Full Text] [Related]
14. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M
Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493
[TBL] [Abstract][Full Text] [Related]
15. The Expanding Field of Biologics in the Management of Chronic Urticaria.
Joshi S; Khan DA
J Allergy Clin Immunol Pract; 2017; 5(6):1489-1499. PubMed ID: 28734860
[TBL] [Abstract][Full Text] [Related]
16. Justification for IgE as a therapeutic target in chronic spontaneous urticaria.
Sánchez-Borges M; Capriles-Hulet A; Caballero-Fonseca F; González-Aveledo L
Eur Ann Allergy Clin Immunol; 2017 Jul; 49(4):148-153. PubMed ID: 28752717
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.
Gimenez-Arnau AM; Salman A; Podder I
Eur J Dermatol; 2024 Feb; 34(1):3-12. PubMed ID: 38557452
[TBL] [Abstract][Full Text] [Related]
18. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune chronic spontaneous urticaria.
Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
